iib-UNSAM

What iib-UNSAM does

IIB-UNSAM (Instituto de Investigaciones Biotecnológicas) is a public Argentine research and education institute jointly operated by Universidad Nacional de San Martín (UNSAM) and the Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET). It operates two campuses — a 4,000 m2 facility at UNSAM's Campus Miguelete in San Martín (including a 600 m2 BSL3 biosafety laboratory) and a 5,000 m2 facility with a 906-hectare experimental field at INTECH in Chascomús — and conducts research across biochemistry, molecular biology, cellular biology, neurobiology, microbiology, and immunology, with applications in human and animal health, agriculture, and industry.

Core outputs span four streams: (1) R&D programs including vaccine development (notably the ANMAT-approved ARVAC-Cecilia Grierson COVID-19 vaccine distributed via Laboratorio Cassará, and the SENASA-approved Delta-PGM brucellosis vaccine), diagnostic tests (CHEMSTRIP COVID-19 IgM/IgG), recombinant proteins, animal reproduction and genetic improvement, and aquaculture; (2) high-level technological services (STAN) offering water analysis, histotechniques, fermentation, fungal species identification, and agricultural consulting on a fee basis; (3) academic programs including the Licenciatura en Biotecnología and the CONEAU Categoría A Doctorate in Molecular Biology and Biotechnology; and (4) the Bioemprendedores (Bioloop) bioentrepreneurship platform.

The institute is funded primarily by Argentine public research grants through CONICET and UNSAM, with supplementary fee income from STAN services and indirect commercialization through partnerships (Cassará for vaccines, R-BIOPHARM licensing of hybridoma cell lines). Customer segments are institutional: scientific researchers, CONICET and UNSAM, undergraduate and doctoral students, agricultural and healthcare organizations purchasing STAN services, and the Argentine public health system via vaccine distribution. There are no private shareholders, external investors, or commercial funding rounds.

Name

iib-UNSAM

Legal name

Instituto de Investigaciones Biotecnológicas (IIB-UNSAM)

Website

https://iib.unsam.edu.ar

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

IIB-UNSAM is a public Argentine biotechnology research institute under UNSAM and CONICET, conducting R&D in molecular biology, immunology, vaccines, and agricultural biotechnology while training students through Licenciatura and doctoral programs and offering fee-based technology services (STAN) and the Bioemprendedores bioentrepreneurship platform.

Ownership category

akta.pro rank

Product category

Biotechnology Research

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro industry

PRIMARYHLAGAIAF

Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Laboratory Equipment, Instruments & Consumables

SECONDARYHLAAAIAL

Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries)

Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)

Keywords

• Biotechnology research
• Molecular biology
• Vaccine development
• Agricultural biotechnology
• Diagnostic development

Headquarters

HQ city

San Martín

HQ country

Argentina

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. Government Research Funding: Funded by CONICET and UNSAM through public research grants, fellowships, and institutional support
2. Technology Services (STAN): High-Level Technological Services providing fee-based analytical, consulting, and testing services to external institutions and companies

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

IIB-UNSAM is a public biotechnology research institute that conducts basic and applied scientific research in biochemistry, molecular biology, cellular biology, neurobiology, microbiology, and immunology. It delivers graduate education (Doctorado en Biología Molecular y Biotecnología, CONEAU Category A) and undergraduate biotechnology training, and operates the STAN technology services platform providing fee-based analytical, consulting, and testing services (water analysis, fermentation, histology, animal reproduction, fungal identification) to public and private institutions.

Product overview

IIB-UNSAM is a research institute offering technological services through its Servicios Tecnológicos de Alto Nivel (STAN) platform, which provides standardized services including agricultural reproduction, water analysis, fermentation processes, histotechnical services, and fungal species identification to public and private institutions. The institute conducts R&D in vaccine development, diagnostic methods, recombinant proteins, and genetic improvement. It also operates an educational division offering a Doctorate in Molecular Biology and Biotechnology (Category A) and undergraduate Biotechnology degree, and maintains a Bioemprendedores (Bioloop) platform for biotech entrepreneurship training.

Differentiator

Problem solved

Functional benefit

Brands

• Escuela de Bio y Nanotecnologías (EByN): Academic school integrating IIB, INTECH, and Instituto de Nanosistemas
• STAN - Servicios Tecnológicos de Alto Nivel
• Bioemprendedores

Products and services

• Servicios Tecnológicos de Alto Nivel (STAN) A standardized technological services platform providing assays, analyses, and institutional consulting services to public institutions and private companies through CONICET, encompassing agricultural, water analysis, histological, and fermentative processes.
• Doctorado en Biología Molecular y Biotecnología Doctoral program (Category A, CONEAU Resolution 138/2022) in Molecular Biology and Biotechnology, with 4-year duration including 528 hours of curricular activities and 4800 hours for thesis research, aimed at training advanced scientific researchers.
• Licenciatura en Biotecnología

Quantifiable outcome

• ARVAC vaccine reached pharmacies nationwide in Argentina (2024)
• +3 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Nine partnerships are on record, tiered minor, major and core.

• INCUCAIminorStrategic or Co-development Partner · 24 September 2023Collaboration agreement for scientific research support in organ transplantation-related biotechnology.
• Tomorrow FoodsminorStrategic or Co-development Partner · 22 August 2023Collaboration on plant-based protein research and alternative protein development projects.
• R-BIOPHARM (Germany)majorOEM/ Whitelabel/ Licensing Partner · 12 August 2022German company licensed the hybridoma cell line technology developed at IIB-UNSAM for monoclonal antibody production.
• CENIT (Centro de Investigaciones para la Transformación)minorStrategic or Co-development Partner · 1 January 2021Collaboration with UNSAM's research center for transformation studies, including bioeconomy and biotechnology innovation.
• CONICETcoreStrategic or Co-development PartnerJoint governance partnership with CONICET for research institute operation. CONICET provides researchers, funding, and institutional support. The IIB-UNSAM is one of the premier research institutes under this partnership.
• Universidad Nacional de San Martín (UNSAM)coreStrategic or Co-development PartnerParent university providing institutional framework, academic programs, and campus facilities. IIB-UNSAM is integral to UNSAM's School of Bio and Nanotechnologies.
• Laboratorio CassarácoreStrategic or Co-development PartnerStrategic partnership for vaccine development and production. ARVAC-Cecilia Grierson vaccine was developed with and is manufactured by Laboratorio Cassará for nationwide distribution.
• ChemtestmajorStrategic or Co-development PartnerPartnership for development of COVID-19 diagnostic tests, including rapid antibody tests and antigen detection kits approved by ANMAT.
• Universidad de GeorgetownminorStrategic or Co-development PartnerStudent exchange program where Georgetown University students conduct research internships at IIB-UNSAM, coordinated by INFANT Center.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Institut Curie: French public-interest research center combining basic research in biology, chemistry, and translational medicine with hospital-based care. Comparable in combining fundamental research, technology transfer, and clinical translation in life sciences.
• Instituto Butantan: Brazilian public research institute producing vaccines and biopharmaceuticals through both its own R&D and partnerships. Directly comparable to IIB-UNSAM as a Latin American public-sector vaccine developer with similar mission, regulatory environment, and biotech research scope.
• Garvan Institute of Medical Research: Australian medical research institute focused on genomics, immunology, and molecular medicine with graduate training programs. Comparable in combining basic research, technology platforms, and PhD education in molecular biology and biotechnology.
• Institut Pasteur: French non-profit foundation dedicated to infectious disease research, vaccine development, and graduate training. Comparable in combining basic research, vaccine development, diagnostic innovation, and educational programs within a public-interest non-commercial structure.
• Broad Institute: MIT/Harvard-affiliated genomics and biomedical research organization conducting large-scale molecular biology, genomic sequencing, and infectious disease research. Comparable in research focus (molecular biology, genomics tools, infectious disease) though operating at much larger scale and with different funding structure.
• Cinvestav (Centro de Investigación y de Estudios Avanzados del IPN): Mexican public research center conducting biotechnology, molecular biology, and biomedical research with graduate programs. Comparable as a Latin American public research institution with similar mission, scale, and academic structure.
• Weizmann Institute of Science: Israeli public-interest research institution conducting multidisciplinary science including molecular biology, biochemistry, and immunology with PhD programs. Comparable in combining basic research, graduate education, technology transfer, and patent generation in life sciences.
• Fundação Oswaldo Cruz (Fiocruz): Brazilian public health research foundation conducting biomedical R&D, vaccine production, and graduate education. Comparable to IIB-UNSAM in mission (public health + academic training + technology transfer), scale, and government-funded model across Latin America.

Regional players

• INTI (Instituto Nacional de Tecnología Industrial): Argentine public industrial technology institute providing testing, calibration, and R&D services to industry. Comparable in providing fee-based technological services (analogous to STAN) to public and private organizations in Argentina.
• INTA (Instituto Nacional de Tecnología Agropecuaria): Argentine public agricultural research institute conducting biotech, animal reproduction, crop improvement, and aquaculture research. Directly comparable to IIB-UNSAM's agricultural biotech operations and experimental field station at Chascomús (INTECH).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks4 records

Key highlights7 records

Customer concentration

• Xx.com/K1000AS
• LinkedInlinkedin.com/company/iib-unsam

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iib-UNSAM